moxifloxacin has been researched along with flomoxef in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (flomoxef) | Trials (flomoxef) | Recent Studies (post-2010) (flomoxef) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 210 | 25 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ | 1 |
2 other study(ies) available for moxifloxacin and flomoxef
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora.
Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan | 2018 |